Fig. 8
From: Unveiling CCR9 and CCL13 as immune biomarkers and therapeutic targets in thymoma
Validation of biomarkers through biological experiments. The protein and mRNA expression of CCR9 and CCL13 were further validated in clinical tissue by Real-time polymerase chain reaction (RT-qPCR) (A), Western blotting (B), and Immunohistochemistry (IHC) (C). Original blots are presented in Supplementary Fig. 3. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
